These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29781571)

  • 1. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B; Patin F; Elion J; Couque N
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.
    Allaf B; Pondarre C; Allali S; De Montalembert M; Arnaud C; Barrey C; Benkerrou M; Benhaim P; Bensaid P; Brousse V; Dollfus C; Eyssette-Guerreau S; Galacteros F; Gajdos V; Garrec N; Guillaumat C; Guitton C; Monfort-Gouraud M; Gouraud F; Holvoet L; Ithier G; Kamdem A; Koehl B; Malric A; Missud F; Monier B; Odièvre MH; Joly P; Renoux C; Patin F; Pissard S; Couque N
    Clin Chem Lab Med; 2020 Aug; 59(1):209-216. PubMed ID: 32813673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B
    Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
    Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
    Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
    J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.
    Moat SJ; Rees D; George RS; King L; Dodd A; Ifederu A; Ramgoolam T; Hillier S
    Ann Clin Biochem; 2017 Sep; 54(5):601-611. PubMed ID: 28656815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening.
    Wild BJ; Green BN; Stephens AD
    Blood Cells Mol Dis; 2004; 33(3):308-17. PubMed ID: 15528150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    McGann PT; Schaefer BA; Paniagua M; Howard TA; Ware RE
    Am J Hematol; 2016 Feb; 91(2):205-10. PubMed ID: 26537622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies.
    Eastman JW; Wong R; Liao CL; Morales DR
    Clin Chem; 1996 May; 42(5):704-10. PubMed ID: 8653895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ; Rees D; King L; Ifederu A; Harvey K; Hall K; Lloyd G; Morrell C; Hillier S
    Clin Chem; 2014 Feb; 60(2):373-80. PubMed ID: 24158758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry.
    Tesorero R; Janda J; Hörster F; Feyh P; Mütze U; Hauke J; Schwarz K; Kunz JB; Hoffmann GF; Okun JG
    PLoS One; 2023; 18(3):e0283024. PubMed ID: 36897914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
    Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
    Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Screening for Sickle Cell Disease in Western Andalusia: Results and Lessons Learnt after 3 Years of Implementation.
    Núñez-Jurado D; Payán-Pernía S; Álvarez-Ríos AI; Jiménez-Jambrina M; Concepcion Pérez-De-Soto I; José Palma-Vallellano A; Zapata-Bautista R; Carlos Hernández-Castellet J; Paz Garrastazul-Sánchez M; Arqueros-Martínez V; Urbano-Ramos MDM; Abdelkader-Maanan M; Raúl García-Lozano J; Delgado-Pecellín C
    Am J Perinatol; 2024 May; 41(S 01):e893-e900. PubMed ID: 36580977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening for sickle cell disease using tandem mass spectrometry.
    Boemer F; Ketelslegers O; Minon JM; Bours V; Schoos R
    Clin Chem; 2008 Dec; 54(12):2036-41. PubMed ID: 18832473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief review on newborn screening methods for hemoglobinopathies and preliminary results selecting beta thalassemia carriers at birth by quantitative estimation of the HbA fraction.
    Mantikou E; Arkesteijn SG; Beckhoven van JM; Kerkhoffs JL; Harteveld CL; Giordano PC
    Clin Biochem; 2009 Dec; 42(18):1780-5. PubMed ID: 19733162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.